Suchergebnisse - "De Simone, Nicole"

PubPharm (38)

1

Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease

enthalten in: Journal of clinical apheresis | 2023

von Choi, J. | Markantonis, J. | De Simone, N. | +3

2

Laboratory-guided repeat dosing of idarucizumab for dabigatran reversal

enthalten in: Clinical toxicology (Philadelphia, Pa.) | 2023

von Jones, H. | De Simone, N. | Webb, C.

3

Red blood cells as glucose carriers to the human brain : Modulation of cerebral activity by erythrocyte exchange transfusion in Glut1 deficiency (G1D)

enthalten in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism | 2023

von Wang, R. | Lee, E. | De Simone, N. | +10

4

Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease

enthalten in: Journal of Clinical Apheresis | 2023

von Choi, J. | Markantonis, J. | De Simone, N. | +3

5

High versus low fixed-dose four factor-prothrombin complex concentrate for warfarin reversal in patients with intracranial hemorrhage

enthalten in: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2022

von Compton, F. | Hall, J. | De Simone, N. | +3

6

Monitoring the therapeutic effect of caplacizumab by von Willebrand Factor activity assays : Proceed with caution

enthalten in: Journal of thrombosis and thrombolysis | 2021

von Yates, S. | Deutsch, D. | Sarode, R. | +1

7

Observed incidence of hypofibrinogenemia in cirrhotic patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Usmani, A. | Laknezhad, S. | De Simone, N. | +2

CommentOn: Liver Int. 2021 Aug;41(8):1901-1908. - PMID 33969607

8

Is a 20 gauge fenestrated intravenous catheter non-inferior to a 18 gauge standard catheter for apheresis procedures? A pilot study

enthalten in: Journal of clinical apheresis | 2021

von Armendariz, T. | West, J. | Olson, D. | +2

9

Immune checkpoint inhibitor toxicity : A new indication for therapeutic plasma exchange?

enthalten in: Journal of clinical apheresis | 2021

von Compton, F. | He, L. | Sarode, R. | +5

10

Monitoring the therapeutic effect of caplacizumab by von Willebrand Factor activity assays: Proceed with caution

enthalten in: Journal of thrombosis and thrombolysis | 2021

von Yates, S. | Deutsch, D. | Sarode, R. | +1